Literature DB >> 17890420

Exact location of the region responsible for the extended substrate spectrum in class C beta-lactamases.

Sang Hee Lee, Jung Hun Lee, Myong Jin Heo, Il Kwon Bae, Seok Hoon Jeong, Sun-Shin Cha.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17890420      PMCID： PMC2043277          DOI： 10.1128/AAC.00633-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Minimising antibiotic resistance.

Authors:  Sang Hee Lee; Seok Hoon Jeong; Sun-Shin Cha
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

2.  Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase.

Authors:  Jae Young Kim; Ha Il Jung; Young Jun An; Jung Hun Lee; So Jung Kim; Seok Hoon Jeong; Kye Joon Lee; Pann-Ghill Suh; Heung-Soo Lee; Sang Hee Lee; Sun-Shin Cha
Journal:  Mol Microbiol       Date:  2006-05       Impact factor: 3.501

3.  Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19.

Authors:  Jun-ichi Wachino; Hiroshi Kurokawa; Satowa Suzuki; Kunikazu Yamane; Naohiro Shibata; Kouji Kimura; Yasuyoshi Ike; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion.

Authors:  G V Crichlow; A P Kuzin; M Nukaga; K Mayama; T Sawai; J R Knox
Journal:  Biochemistry       Date:  1999-08-10       Impact factor: 3.162

5.  Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.

Authors:  G Barnaud; R Labia; L Raskine; M J Sanson-Le Pors; A Philippon; G Arlet
Journal:  FEMS Microbiol Lett       Date:  2001-02-20       Impact factor: 2.742

6.  AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.

Authors:  Hedi Mammeri; Hasan Nazic; Thierry Naas; Laurent Poirel; Sophie Léotard; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.

Authors:  Yohei Doi; Jun-ichi Wachino; Masaji Ishiguro; Hiroshi Kurokawa; Kunikazu Yamane; Naohiro Shibata; Keigo Shibayama; Keiko Yokoyama; Haru Kato; Tetsuya Yagi; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

8.  Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate.

Authors:  G Barnaud; Y Benzerara; J Gravisse; L Raskine; M J Sanson-Le Pors; R Labia; G Arlet
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

9.  Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate.

Authors:  Hedi Mammeri; Laurent Poirel; Pascal Bemer; Henri Drugeon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191
  9 in total
  2 in total

Review 1.  Class C β-Lactamases: Molecular Characteristics.

Authors:  Alain Philippon; Guillaume Arlet; Roger Labia; Bogdan I Iorga
Journal:  Clin Microbiol Rev       Date:  2022-04-18       Impact factor: 50.129

Review 2.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.